97 research outputs found

    HIFI Spectroscopy of H2O{\rm H_2O} submm Lines in Nuclei of Actively Star Forming Galaxies

    Get PDF
    We present a systematic survey of multiple velocity-resolved H2_2O spectra using Herschel/HIFI towards nine nearby actively star forming galaxies. The ground-state and low-excitation lines (Eup130K_{\rm up}\,\le 130\,{\rm K}) show profiles with emission and absorption blended together, while absorption-free medium-excitation lines (130KEup350K130\,{\rm K}\, \le\, E_{\rm up}\,\le\,350\,{\rm K}) typically display line shapes similar to CO. We analyze the HIFI observation together with archival SPIRE/PACS H2_2O data using a state-of-the-art 3D radiative transfer code which includes the interaction between continuum and line emission. The water excitation models are combined with information on the dust- and CO spectral line energy distribution to determine the physical structure of the interstellar medium (ISM). We identify two ISM components that are common to all galaxies: A warm (Tdust4070KT_{\rm dust}\,\sim\,40-70\,{\rm K}), dense (n(H)105106cm3n({\rm H})\,\sim\,10^5-10^6\,{\rm cm^{-3}}) phase which dominates the emission of medium-excitation H2_2O lines. This gas phase also dominates the FIR emission and the CO intensities for Jup>8J_{\rm up} > 8. In addition a cold (Tdust2030KT_{\rm dust}\,\sim\,20-30\,{\rm K}), dense (n(H)104105cm3n({\rm H})\sim\,10^4- 10^5\,{\rm cm^{-3}}) more extended phase is present. It outputs the emission in the low-excitation H2_2O lines and typically also produces the prominent line absorption features. For the two ULIRGs in our sample (Arp 220 and Mrk 231) an even hotter and more compact (Rs100_s\,\le\,100 pc) region is present which is possibly linked to AGN activity. We find that collisions dominate the water excitation in the cold gas and for lines with Eup300KE_{\rm up}\le300\,{\rm K} and Eup800KE_{\rm up}\le800\,{\rm K} in the warm and hot component, respectively. Higher energy levels are mainly excited by IR pumping.Comment: Accepted by ApJ, in pres

    Advances in methods to obtain and characterise room temperature magnetic ZnO

    Get PDF
    We report the existence of magnetic order at room temperature in Li-doped ZnO microwires after low energy H+ implantation. The microwires with diameters between 0.3 and 10 μm were prepared by a carbothermal process. We combine spectroscopy techniques to elucidate the influence of the electronic structure and local environment of Zn, O, and Li and their vacancies on the magnetic response. Ferromagnetism at room temperature is obtained only after implanting H+ in Li-doped ZnO. The overall results indicate that low-energy proton implantation is an effective method to produce the necessary amount of stable Zn vacancies near the Li ions to trigger the magnetic order.Instituto de Física La Plat

    Optical and ultraviolet pulsed emission from an accreting millisecond pulsar

    Get PDF
    Millisecond spinning, low-magnetic-field neutron stars are believed to attain their fast rotation in a 0.1–1-Gyr-long phase during which they accrete matter endowed with angular momentum from a low-mass companion star1. Despite extensive searches, coherent periodicities originating from accreting neutron star magnetospheres have been detected only at X-ray energies2 and in ~10% of the currently known systems3. Here we report the detection of optical and ultraviolet coherent pulsations at the X-ray period of the transient low-mass X-ray binary system SAX J1808.4−3658, during an accretion outburst that occurred in August 20194. At the time of the observations, the pulsar was surrounded by an accretion disk, displayed X-ray pulsations and its luminosity was consistent with magnetically funnelled accretion onto the neutron star. Current accretion models fail to account for the luminosity of both optical and ultraviolet pulsations; these are instead more likely to be driven by synchro-curvature radiation5,6 in the pulsar magnetosphere or just outside of it. This interpretation would imply that particle acceleration can take place even when mass accretion is going on, and opens up new perspectives in the study of coherent optical/ultraviolet pulsations from fast-spinning accreting neutron stars in low-mass X-ray binary systems

    Modified Gravity and Cosmology

    Get PDF
    In this review we present a thoroughly comprehensive survey of recent work on modified theories of gravity and their cosmological consequences. Amongst other things, we cover General Relativity, Scalar-Tensor, Einstein-Aether, and Bimetric theories, as well as TeVeS, f(R), general higher-order theories, Horava-Lifschitz gravity, Galileons, Ghost Condensates, and models of extra dimensions including Kaluza-Klein, Randall-Sundrum, DGP, and higher co-dimension braneworlds. We also review attempts to construct a Parameterised Post-Friedmannian formalism, that can be used to constrain deviations from General Relativity in cosmology, and that is suitable for comparison with data on the largest scales. These subjects have been intensively studied over the past decade, largely motivated by rapid progress in the field of observational cosmology that now allows, for the first time, precision tests of fundamental physics on the scale of the observable Universe. The purpose of this review is to provide a reference tool for researchers and students in cosmology and gravitational physics, as well as a self-contained, comprehensive and up-to-date introduction to the subject as a whole.Comment: 312 pages, 15 figure

    f(R) theories

    Get PDF
    Over the past decade, f(R) theories have been extensively studied as one of the simplest modifications to General Relativity. In this article we review various applications of f(R) theories to cosmology and gravity - such as inflation, dark energy, local gravity constraints, cosmological perturbations, and spherically symmetric solutions in weak and strong gravitational backgrounds. We present a number of ways to distinguish those theories from General Relativity observationally and experimentally. We also discuss the extension to other modified gravity theories such as Brans-Dicke theory and Gauss-Bonnet gravity, and address models that can satisfy both cosmological and local gravity constraints.Comment: 156 pages, 14 figures, Invited review article in Living Reviews in Relativity, Published version, Comments are welcom

    Investigating the origin of optical and X-ray pulsations of the transitional millisecond pulsar PSR J1023+0038

    Get PDF
    Context. PSR J1023+0038 is the first millisecond pulsar that was ever observed as an optical and UV pulsar. So far, it is the only optical transitional millisecond pulsar. The rotation- and accretion-powered emission mechanisms hardly individually explain the observed characteristics of optical pulsations. A synergistic model, combining these standard emission processes, was proposed to explain the origin of the X-ray/UV/optical pulsations. Aims: We study the phase lag between the pulses in the optical and X-ray bands to gain insight into the physical mechanisms that cause it. Methods: We performed a detailed timing analysis of simultaneous or quasi-simultaneous observations in the X-ray band, acquired with the XMM-Newton and NICER satellites, and in the optical band, with the fast photometers SiFAP2 (mounted at the 3.6 m Telescopio Nazionale Galileo) and Aqueye+ (mounted at the 1.8 m Copernicus Telescope). We estimated the time lag of the optical pulsation with respect to that in the X-rays by modeling the folded pulse profiles with two harmonic components. Results: Optical pulses lag the X-ray pulses by ∼150 μs in observations acquired with instruments (NICER and Aqueye+) whose absolute timing uncertainty is much smaller than the measured lag. We also show that the phase lag between optical and X-ray pulsations lies in a limited range of values, δϕ ∈ (0 − 0.15), which is maintained over timescales of about five years. This indicates that both pulsations originate from the same region, and it supports the hypothesis of a common emission mechanism. Our results are interpreted in the shock-driven mini pulsar nebula scenario. This scenario suggests that optical and X-ray pulses are produced by synchrotron emission from the shock that formed within a few light cylinder radii away (∼100 km) from the pulsar, where its striped wind encounters the accretion disk inflow

    Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Get PDF

    The LOFT mission concept: a status update

    Get PDF
    The Large Observatory For x-ray Timing (LOFT) is a mission concept which was proposed to ESA as M3 and M4 candidate in the framework of the Cosmic Vision 2015-2025 program. Thanks to the unprecedented combination of effective area and spectral resolution of its main instrument and the uniquely large field of view of its wide field monitor, LOFT will be able to study the behaviour of matter in extreme conditions such as the strong gravitational field in the innermost regions close to black holes and neutron stars and the supra-nuclear densities in the interiors of neutron stars. The science payload is based on a Large Area Detector (LAD, >8m2 effective area, 2-30 keV, 240 eV spectral resolution, 1 degree collimated field of view) and a Wide Field Monitor (WFM, 2-50 keV, 4 steradian field of view, 1 arcmin source location accuracy, 300 eV spectral resolution). The WFM is equipped with an on-board system for bright events (e.g., GRB) localization. The trigger time and position of these events are broadcast to the ground within 30 s from discovery. In this paper we present the current technical and programmatic status of the mission

    The Large Observatory for x-ray timing

    Get PDF
    The Large Observatory For x-ray Timing (LOFT) was studied within ESA M3 Cosmic Vision framework and participated in the final down-selection for a launch slot in 2022-2024. Thanks to the unprecedented combination of effective area and spectral resolution of its main instrument, LOFT will study the behaviour of matter under extreme conditions, such as the strong gravitational field in the innermost regions of accretion flows close to black holes and neutron stars, and the supra-nuclear densities in the interior of neutron stars. The science payload is based on a Large Area Detector (LAD, 10 m2 effective area, 2-30 keV, 240 eV spectral resolution, 1° collimated field of view) and a WideField Monitor (WFM, 2-50 keV, 4 steradian field of view, 1 arcmin source location accuracy, 300 eV spectral resolution). The WFM is equipped with an on-board system for bright events (e.g. GRB) localization. The trigger time and position of these events are broadcast to the ground within 30 s from discovery. In this paper we present the status of the mission at the end of its Phase A study

    Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Get PDF
    Background: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke. Methods: We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515. Findings: Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group. Interpretation: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes. Funding: GlaxoSmithKline
    corecore